REX American Resources Corporation logo

REX American Resources Corporation

REX

NYSEBasic MaterialsChemicals

Previous close

$44.67

+$0.28 · +0.63%

Aug 21, 4:00 PM ET

REX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

87

Deep Value

Momentum

53

Neutral

Sentiment

62

Bullish

Risk resilience

68

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

REX American Resources Corporation, along with its various subsidiaries, manufactures and distributes ethanol across the United States. The company's product portfolio extends to include corn, distillers grains, industrial-grade corn oil, gasoline, and natural gas. Notably, they also supply dry distillers grains with solubles, an important protein component used in animal feed. Established in 1980, the firm initially operated as REX Stores Corporation before adopting its present name, REX American Resources Corporation, in 2010. Its corporate base is situated in Dayton, Ohio.

Industry
Chemicals
Sector
Basic Materials
Headquarters
US
CEO
Zafar A. Rizvi
Listed since
Jul 17, 1984
Employees
132

Market position

Day range

Current $44.67

52-week range

Current $44.67

Open
$44.93
Previous close
$44.39
Volume
85.31K
0.46× average
Average volume
185.35K
Average daily volume
Market cap
1.47B USD
Beta
0.64
Market reference 1
50-day average
$44.592
+0.17% above average
200-day average
$40.3088
+10.82% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
955.3M USD
P/E (TTM)
15.9×
P/B (TTM)
2.35×
P/S (TTM)
2.24×
EV / EBITDA
9.07×
Earnings yield
7.39%
Free cash flow yield
4.40%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
16.52%
Operating margin
10.98%
Net margin
14.13%
Return on equity
13.58%
Return on assets
10.40%
Return on invested capital
8.37%

Financial health

Debt / equity
0.03×
Current ratio
5.94×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends16%11%6%2%Gross margin, FY2021: 12.59%Gross margin, FY2022: 5.68%Gross margin, FY2023: 11.79%Gross margin, FY2024: 14.24%Gross margin, FY2025: 14.41%Operating margin, FY2021: 8.92%Operating margin, FY2022: 3.01%Operating margin, FY2023: 8.26%Operating margin, FY2024: 10.01%Operating margin, FY2025: 9.39%Net margin, FY2021: 6.76%Net margin, FY2022: 3.24%Net margin, FY2023: 7.31%Net margin, FY2024: 9.05%Net margin, FY2025: 12.75%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 12.59%. Gross margin FY2022 5.68%. Gross margin FY2023 11.79%. Gross margin FY2024 14.24%. Gross margin FY2025 14.41%. Operating margin FY2021 8.92%. Operating margin FY2022 3.01%. Operating margin FY2023 8.26%. Operating margin FY2024 10.01%. Operating margin FY2025 9.39%. Net margin FY2021 6.76%. Net margin FY2022 3.24%. Net margin FY2023 7.31%. Net margin FY2024 9.05%. Net margin FY2025 12.75%.

Income trends

Revenue

650.49M USD+1.24%

Operating income

61.09M USD-5.04%

Net income

82.95M USD+42.61%
Income trends across reported periods937.92M USD606.23M USD274.54M USD−57.15M USDRevenue, FY2021: 774.8M USDRevenue, FY2022: 855M USDRevenue, FY2023: 833.38M USDRevenue, FY2024: 642.49M USDRevenue, FY2025: 650.49M USDOperating income, FY2021: 69.08M USDOperating income, FY2022: 25.78M USDOperating income, FY2023: 68.84M USDOperating income, FY2024: 64.33M USDOperating income, FY2025: 61.09M USDNet income, FY2021: 52.36M USDNet income, FY2022: 27.7M USDNet income, FY2023: 60.94M USDNet income, FY2024: 58.17M USDNet income, FY2025: 82.95M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 774.8M USD. Revenue FY2022 855M USD. Revenue FY2023 833.38M USD. Revenue FY2024 642.49M USD. Revenue FY2025 650.49M USD. Operating income FY2021 69.08M USD. Operating income FY2022 25.78M USD. Operating income FY2023 68.84M USD. Operating income FY2024 64.33M USD. Operating income FY2025 61.09M USD. Net income FY2021 52.36M USD. Net income FY2022 27.7M USD. Net income FY2023 60.94M USD. Net income FY2024 58.17M USD. Net income FY2025 82.95M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue650.49M USD642.49M USD833.38M USD855M USD774.8M USD
Cost of goods sold556.78M USD551.01M USD735.17M USD806.4M USD677.24M USD
Gross profit93.71M USD91.48M USD98.22M USD48.6M USD97.56M USD
Selling, general, and administrative32.62M USD27.15M USD29.38M USD22.83M USD28.48M USD
Operating expenses32.62M USD27.15M USD29.38M USD22.83M USD28.48M USD
Interest income15M USD19.16M USD15.72M USD12.96M USD130K USD
Depreciation and amortization16.76M USD21.72M USD23.04M USD23.3M USD23.59M USD
Operating income61.09M USD64.33M USD68.84M USD25.78M USD69.08M USD
Net income82.95M USD58.17M USD60.94M USD27.7M USD52.36M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
2.5
FY2025 · +51.52% year over year
Latest fiscal-year revenue
650.49M USD
FY2025 · +1.24% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend2.671.991.30.61FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend876.25M791.25M706.24M621.24MFY21FY22FY23FY24FY25

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$60.00

34.32% upside
Past 12 months12-month forecastHigh $60.00Average $60.00Low $60.00

REX news

Corporate actions

Corporate action history

Stock split

Effective Sep 16, 2025

2:1

Stock split

Effective Aug 8, 2022

3:1

Stock split

Effective Feb 12, 2002

3:2

Stock split

Effective Aug 13, 2001

3:2

Stock split

Effective Apr 21, 1986

3:2

Stock split

Effective Jun 25, 1985

3:2

REX peers

ETFs holding REX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research REX

research.disclaimer